Government of Congo Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2020
NCT04618523
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

INRB | Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo | Institut National de Research Biomédicale

Active Ingredients

Drugs in Phase 4 Trials (5)

amodiaquine (camoquin) (1 trial)

artemether (1 trial)

artesunate (1 trial)

lumefantrine (Coartem) (1 trial)

vi-dt typhoid conjugate vaccine (1 trial)

Drugs in Other Trials (1)

2B1 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6